A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy Subjects
Clinical trial NCT03410979 · COMPLETED
Trial details
- NCT number
- NCT03410979
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-25
- Primary completion
- 2017-08-15
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.